Citadel Advisors »

Protagenic Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Protagenic Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $30k 23k 1.30

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Protagenic Therapeutics

DRW Holdings
FNY Investment Advisers
Citadel Advisors
Geode Capital Management
Raymond James Financial
Tower Research Capital
CoreCap Advisors
Advisor Group Holdings
CWM
Harbor Investment Advisory

View all funds holding Protagenic Therapeutics